Cargando…
Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared this outbreak a pandemic. Vaccines are an effective way to prevent the rapid spread of COVID-19. Furthermore, the immune response...
Autores principales: | Kim, Kyun-Do, Hwang, Insu, Ku†, Keun Bon, Lee, Sumin, Kim, Seong-Jun, Kim, Chonsaeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Microbiology and Biotechnology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728398/ https://www.ncbi.nlm.nih.gov/pubmed/32627758 http://dx.doi.org/10.4014/jmb.2006.06006 |
Ejemplares similares
-
Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung
por: Shin, Hye Jin, et al.
Publicado: (2021) -
Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2
por: Ku, Keun Bon, et al.
Publicado: (2020) -
Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern
por: Jeong, Gi Uk, et al.
Publicado: (2021) -
A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses
por: Ahn, Dae-Gyun, et al.
Publicado: (2021) -
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2
por: Jung, Hi Eun, et al.
Publicado: (2023)